	Genetics and Screening in Prostate Cancer. Surg Clin North Am Partuzo JGR, Mora-Garijo B, Hwang J. PMID: 42419315 [PubMed - indexed for MEDLINE]
	Identification and verification of immunogenic cell death-related signatures derived from bone metastasis of prostate cancer based on multi-omics and machine learning algorithms. Comput Biol Chem Ma W, Mei W, Guang L, Yang Q, Xu M, Zhou H. PMID: 42419189 [PubMed - as supplied by publisher]
	The cancer/testis antigens represent promising targets for the development of new therapies against melanoma. Pathol Res Pract Lanius SL, Pacheco BS, Sousa FSS, Ehlert ME, Ferreira VG, Collares TV, Seixas FK. PMID: 42419156 [PubMed - as supplied by publisher]
	Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'? J Pathol Schepisi G, Torresan I, Giunta EF, Bleve S, Brighi N, Tassinari E, Zanuccoli S, Cursano MC, Lolli C. PMID: 42420213 [PubMed - as supplied by publisher]
	Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making. Eur Urol Oncol Thibault C, Blons H, Allory Y, Harba A, Roumiguié M, Seisen T, Marcq G, Bajeot AS, Leon P, Masson-Lecomte A, Pradère B, Xylinas E, Prost D, Gabriel PE, Laurent-Puig P, Rouprêt M, Audenet F, Cancer Committee of The French Association of Urology (CC-AFU). PMID: 42420157 [PubMed - as supplied by publisher]
	Development and acceptability of gist-based decision aids for prostate and breast cancer screening: a two-phase qualitative interview study in an online setting. BMJ Open Nalavenkata S, Bergengren O, Lynch K, Emard N, Austria M, Martin S, Ogbennaya G, Dualeh K, Stevanovic K, Patel MI, Gonsky J, Vickers A, Fagerlin A, Hamilton JG, Hay JL, Carlsson S. PMID: 42419884 [PubMed - indexed for MEDLINE]
	(Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trial. BMJ Open Te Molder LPW, Sedelaar JPM, Bomers JGR, Boomsma MF, de Haan TD, van Melick HHE, Meijerink MR, Beerlage HP, van Aubel O, Collette ER, Grutters JPC, Hannink G, Rovers MM, Fütterer JJ, ENFORCE Focal consortium. PMID: 42419881 [PubMed - indexed for MEDLINE]
	Advances in systemic therapies for advanced prostate cancer. BMJ Childs DS, Hahn AW, Ravi P, Orme JJ. PMID: 42419784 [PubMed - indexed for MEDLINE]
	Integrating Natural Language Processing With ChatGPT to Improve Quality of Artificial Intelligence Summaries of Prostate Cancer Consultations. JCO Clin Cancer Inform Friedrich NA, Das SK, Luu M, Daniels JP, Heard J, Barsegyan A, Freedland SJ, Spiegel B, Kokorowski PK, Gonzalez Hernandez G, Daskivich TJ. PMID: 42418754 [PubMed - indexed for MEDLINE]
	Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology. JCO Precis Oncol Kamran SC, Borges M, Michalski J, Lee WR, Sandler HM, Crook J, Pollack A, Hurwitz MD, Valicenti RK, Bruner DW, Lukka H, Jones CU, Roach M 3rd, Lawton C, Rosenthal SA, Pisansky TM, Spratt D, Vapiwala N, Efstathiou J, Miyamoto D, Mouw K, Vyfhuis M, Le QT, Willers H, Van Allen E, Huang F, Bahary JP, Helou J, Pugh SL, Wenzel J, Tran P. PMID: 42418740 [PubMed - indexed for MEDLINE]
	Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials. JCO Precis Oncol Sweeney CJ, Krishna V, Krishna V, Neema A, Tarsode A, Subhash VV, Horvath LG, Kench JG, Stockler MR, Yip S, Thomas H, Swami U, Zhang H, Sonawane S, Abuzeid WM, Nimgaonkar V, Tiu E, Watson D, Kiedrowski L, Royce TJ, Yang DD, Tran PT, Ryan CJ, Nguyen PL, Morgans AK, Joshi A, Agarwal N, Davis ID. PMID: 42418739 [PubMed - indexed for MEDLINE]
	Shallow Whole-Genome Sequencing to Assess Genomic Instability and Predict Treatment Response in Metastatic Castration-Resistant Prostate Cancer. JCO Precis Oncol Slootbeek PHJ, Quint YM, Kokke JJR, Pamidimarri Naga S, Luna-Velez MV, Ligtenberg MJL, de Voer RM, Mehra N. PMID: 42418738 [PubMed - indexed for MEDLINE]
	Informed Decision Making for Prostate Cancer Screening - A Prospective, Randomized Study of Two Novel Web-based, Electronic Visits. J Urol Presti J Jr, Prausnitz S, Altschuler A, Horton B, Alexeeff S, Avins AL. PMID: 42418618 [PubMed - as supplied by publisher]
	Multimodal imaging to analyze the biomechanical properties of kidney tumors, evaluating feasibility, inter-modality correspondence, and diagnostic value (UroCCR-115). PLoS One Ronca M, Conforti P, Crombé A, Jaffredo M, Ricard S, Colin T, Yacoub M, Le Bras Y, Bernhard JC, Margue G, Fourage-Jambon E. PMID: 42418537 [PubMed - indexed for MEDLINE]
	Development and Advantages of O-(Carboxymethyl)-L-tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer. J Med Chem Li L, Zhao R, Wang G, Jin W, Zhu L, Zhu Z, Kung HF. PMID: 42418373 [PubMed - as supplied by publisher]
	Same-day Hyaluronic Acid rectal spacer for TRUS-guided HDR Prostate Brachytherapy: Feasibility and dosimetric outcomes. J Appl Clin Med Phys Ng SK, Pokhrel D, Huang C, Asamoah FA, Holmes JA, Prabhu A, Ishaq O. PMID: 42418218 [PubMed - indexed for MEDLINE]
	Dual Marker Co-Expressed Exosome-Based Liquid Biopsy Electrochemical Assay for Enhanced-Accuracy Diagnosis of Prostate Cancer. ACS Sens Wei F, Jiang Q, Chen W, Chen F, Zhang M, Yu Y, Guan M, Li S. PMID: 42418184 [PubMed - as supplied by publisher]
	Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study. BJU Int Cannoletta D, Brembilla G, Longoni M, Porzi ME, Quarta L, Santangelo A, Scilipoti P, Zaurito P, Brancaccio M, Scuderi S, Barletta F, Cosenza M, Gandaglia G, Montorsi F, De Cobelli F, Briganti A, Stabile A. PMID: 42417115 [PubMed - as supplied by publisher]
	Endocrine-driven inflammatory-epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis. Front Endocrinol (Lausanne) Gruji, , Alaverdashvili T, Eroglu I, Krasi, Jankovi, Milosavljevi. PMID: 42416899 [PubMed - indexed for MEDLINE]
	Superior cancer detection with transperineal biopsy in patients with an elevated prostate-specific antigen level and a PI-RADS score of 3-4: A retrospective cohort study. Oncol Lett Zhang J, Zheng H. PMID: 42416028 [PubMed]

Articles 1 - 20 / 179858

Page 1 of 8993



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy